Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Ptc Therapeutics (NQ: PTCT ) 33.97 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 33.97 Bid (Size) 13.59 (2) Ask (Size) 54.01 (1) Prev. Close 33.97 Today's Range 33.97 - 33.97 52wk Range 17.53 - 42.14 Shares Outstanding 76,696,785 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News PTC Therapeutics, Inc. (PTCT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings July 10, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire PTC Therapeutics, Inc. (PTCT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings July 03, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire Performance YTD +21.15% +21.15% 1 Month -5.03% -5.03% 3 Month +34.75% +34.75% 6 Month +24.84% +24.84% 1 Year -12.49% -12.49% More News Read More Nike, Accolade And Other Big Stocks Moving Lower In Friday's Pre-Market Session June 28, 2024 Via Benzinga Recap: PTC Therapeutics Q4 Earnings February 29, 2024 Via Benzinga Earnings Scheduled For February 29, 2024 February 29, 2024 Via Benzinga Earnings Preview: PTC Therapeutics February 28, 2024 Via Benzinga Analyst Expectations for PTC Therapeutics's Future November 20, 2023 Via Benzinga PTC Therapeutics Tumbles After European Regulators Reject Its Drug — Again June 28, 2024 Via Investor's Business Daily Asana, Clover Health Investments, Hertz Global And Other Big Stocks Moving Higher On Friday June 21, 2024 Via Benzinga PTC Therapeutics Says FDA Lifts Clinical Hold On Investigational Study In Patients With Rare Weak Nerve Cell Disorder June 20, 2024 Via Benzinga Exposures Product Safety The 3 Most Undervalued Biotech Stocks to Buy in June 2024 June 04, 2024 Via InvestorPlace Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session May 20, 2024 Via Benzinga European Commission Requests Reevaluation Of Opinion On PTC Therapeutics' Duchenne Dystrophy Drug; Pauses Annual Guidance May 20, 2024 Via Benzinga Overseas Shipholding, Micron, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday May 20, 2024 Via Benzinga PTC Therapeutics Stock Soars As Its Biggest Drug 'Lives To Fight Another Day' May 20, 2024 Via Investor's Business Daily 12 Health Care Stocks Moving In Monday's Pre-Market Session May 20, 2024 Via Benzinga PTC Therapeutics Stock Sees IBD RS Rating Climb To 72 May 01, 2024 Via Investor's Business Daily PTCT Stock Earnings: PTC Therapeutics Beats EPS, Beats Revenue for Q1 2024 April 25, 2024 Via InvestorPlace Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday March 01, 2024 Via Benzinga Topics Stocks Exposures US Equities 1 of Sarepta Therapeutics' Competitors Just Got Hammered. Will It Help the Stock? February 11, 2024 Via The Motley Fool PTC Therapeutics Flashes A Bearish Sign After European Officials Reject DMD Drug January 26, 2024 Via Investor's Business Daily PTC Therapeutics To Withdraw Its Conditionally Approved Rare Muscle Disorder Disorder Drug In Europe January 26, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session January 26, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session January 25, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session October 27, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.